Clinical Trial Update: Intravenous High Dose Iron in Blood Donors [Phase 3]

View source ↗

Summary

The document provides an update on a Phase 3 trial evaluating intravenous high-dose iron for iron deficiency in blood donors, with the trial status reported as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency

Drugs mentioned

• Intravenous iron (unspecified formulation) (intravenous iron)

Snippet

Sponsor: Medical University of Graz | Conditions: Iron Deficiency | Phase 3 | Status: COMPLETED